- $77.96m
- $8.61m
- $25.38m
- 10
- 30
- 43
- 16
Annual balance sheet for Invivyd, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 115 | 591 | 372 | 201 | 69.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.377 | 0.933 | 11.2 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 117 | 617 | 377 | 225 | 101 |
Net Property, Plant And Equipment | — | 0.083 | 6.06 | 4.13 | 2.89 |
Other Long Term Assets | |||||
Total Assets | 117 | 620 | 383 | 229 | 130 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.1 | 62.1 | 25 | 50.3 | 62 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 13.1 | 62.1 | 27.2 | 51.7 | 62 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 104 | 558 | 356 | 177 | 67.5 |
Total Liabilities & Shareholders' Equity | 117 | 620 | 383 | 229 | 130 |
Total Common Shares Outstanding |